🎉 Hey iGEM Teams, Big News! 🎉 Twist Bioscience's high-quality DNA synthesis products are now available for order! As a proud sponsor of the iGEM Competition, Twist Bioscience offers exclusive benefits to support your innovative synthetic biology projects. ✨ Why Choose Twist Bioscience for iGEM?✨ 🔹 Precision Gene Fragments 🔹 Custom Oligo Pools 🔹 Special Deals Just for You! How to Get Your Hands on These Awesome Tools: 1) Head over to the Twist iGEM Sponsorship page. 2) Make sure your team is registered on the iGEM website. 3) Log in to your iGEM account and check out the sponsorship section. 4) Click through to Twist Bioscience's ordering platform and pick your products. 5) Don’t forget to use your iGEM discount codes at checkout! Let's take your iGEM project to the next level with Twist Bioscience! 🚀🧬 Questions? Visit the Twist iGEM Sponsorship page or drop us a message: https://lnkd.in/g8YW8Vtw #iGEM #TwistBioscience #SynBioRevolution #DNAGeeks #InnovateWithTwist, iGEM, iGEM Community
Twist Bioscience’s Post
More Relevant Posts
-
If you will be attending the International Complement Workshop (ICW) in Newcastle on August 31 to September 5 - do take the opportunity to meet with my colleagues from Svar. Apart from them being very nice people they are also highly competent in the Complement System and may offer valuable tips on how to study it. #svarlifescience #ICW #complement #complementsystem #FunctionalAndQuantitativeComplementELISAs
An exciting complement event is coming up - The 29th International Complement Workshop (ICW) in Newcastle from August 31 to September 5, 2023. It's a fantastic opportunity for Complementologists to learn about various aspects of complement biology, from activation and control to genetics, therapeutics, and more. This year, we're exhibiting, and we're extra proud to be a part of the agenda as we are hosting a prize ceremony on Friday, Sept. 1 at 16:00 (17:00 CEST), where we'll announce the winners of the Svar Complement Excellence Award. We are also thrilled to present a new scientific poster: "Assessing Function & Inhibition of a Synthetically Assembled C3-Convertase Using a Novel Functional Assay." If you're attending, connect with us and discuss the vital role of the Complement system! #svarlifescience #ICW #complement #complementsystem #svarcomplementexcellenceaward
To view or add a comment, sign in
-
-
🌟 Lipidica at Analytica 2024 in Munich 🔬 The conference took place in the second week of April in Munich and is traditionally part of the leading world trade fair analytica 2024, where the latest trends in laboratory technology, biotechnology and analytical chemistry are presented. This year, the fair was attended by 1,066 exhibitors and 34,000 visitors from all over the world! 🌏 During the conference, more than 180 lectures 👨🏫 were presented by leading experts covering the entire spectrum of modern analytical chemistry. There were, for example, lectures on the topic of innovations in chromatography by Michael Laemmerhofer, pitfalls in lipidomic analysis by Gerhard Liebisch, or issues of sample preparation by Robert Gurke. Among the invited speakers was the representative of the Lipidica, a.s. 👏 Ondřej Peterka, who presented our findings from the beginning of research into the use of lipidomic analysis for the early detection of pancreatic cancer, through the founding of the company Lipidica, a.s. and the transfer of the methodology up to the current state, which is already very close to the launch of the clinical performance study of the lipidomic test (LDPC). 👍 Link to the conference/fair https://lnkd.in/eXPSSR7b Learn more about our method https://www.lipidica.com/ #Analytica2024 #analyticalchemistry #biotechnology #laboratorytechnology #LDPClipidomictest
To view or add a comment, sign in
-
-
🔵 Stay Connected with CPGR! 🧬 CPGR is a key driver in OMICS technology in the South African biosector and even the world at large. Over the years, we have cultivated meaningful connections with pioneers in the field. 🕸 Join our community of forward-thinkers and innovators by subscribing to our exclusive email list. 🔔 By subscribing, you gain access to: ✅ Research Updates: Stay updated with CPGR research and development initiatives. ✅Training and Development Updates: Stay updated on CPGR bursary and OMICS development programs. ✅Event Announcements: Be the first to know about seminars, workshops, and conferences hosted by CPGR and other relevant organizations. ✅Industry News: Receive curated news and insights from the field, keeping you informed about industry trends and breakthrough. 📨 Subscribe here 👇 http://eepurl.com/hbQ1hD #cpgr #OMICS #genomics #proteomics #bioinformatics #connect #networking #science
To view or add a comment, sign in
-
-
From the heart of Brazil 🇧🇷 to the global stage in Switzerland🇨🇭! Aptah Bio, a Vesper Ventures portfolio company, has been handpicked to showcase at the Longevity Investors conference held in Gstaad from the 27th to the 29th of September. Imagine a world where age-related diseases like dementia and cancer could be things of the past! ✨ That’s the potential Aptah Bio is unlocking. Aptah’s unique modulation based technology compound works as a template for RNA processing quality control (RNA homeostasis). Their preliminary results are painting a future where cells could age gracefully, without accumulating errors. Standing shoulder-to-shoulder with global references like Dr. Greg Bailey, Prof. David A. Sinclair and Aubrey de Grey, Aptah will introduce its technology compound with the aim of driving and redefining the future of longevity. Brazil's biotech potential is soaring high, and we're just getting started! Join us in our mission. #RedefiningLongevity #AptahBio #VesperVenutres #biotechbrazil
To view or add a comment, sign in
-
-
Looking forward to seeing some known faces and meeting some new ones! Investing? How commercially viable is the science? What are the product development/CMC and regulatory risks? What is the competitive landscape? Fundraising? Does your pitch deck and data room position your company to be as investable as possible? Promising non-clinical data? How to turn that into a commercial product? What is the best product development and regulatory strategy? Growing pains? Addressing the various resource gaps in regulatory affairs, regulatory operations, clinical operations, clinical and medical affairs, regulatory and medical writing and many more as you transition the product from one phase to another! It has been great to work with innovators and the leaders to help them advance their asset and materialize the vision! Looking forward to connecting further to brainstorm solutions with you! #TexasLifeSciencesSummit #CPRIT #THBI
Next week, Ami Patel, Senior Director of Business Development at Boyds, is looking forward to attending Texas Life Sciences Summit, co-hosted by Texas Healthcare and Bioscience Institute (THBI) and Cancer Prevention and Research Institute of Texas. The Texas Life Sciences Summit will bring together state leaders, life sciences companies, economic development organizations, academic institutions, and service providers that support the ecosystem. 📧 If you are attending and would like to arrange to discuss your drug development program and needs with Ami, contact info@boydconsultants.com. #lifesciences #Texas #THBI #CPRIT
To view or add a comment, sign in
-
-
This month's meeting of the #SGO kicks off this Saturday!! Here we present the titles of the key abstracts that will be presented at the #conference. For further details, conference coverage support, pipeline analysis and other CI services, contact rishi.srivastava@datazymes.com #Immunotherapy, #CancerResearch, #Immunooncology, #CancerTreatment, #Biotechnology, #ImmuneCheckpointInhibitors, #ClinicalTrials, #Biomarkers, #CancerImmunology, #Immunomodulation, #TumorMicroenvironment, #TargetedTherapeutics, #ImmunotherapeuticApproaches, #ImmuneResponse, and #OncologyAdvancements
To view or add a comment, sign in
-
Molecular cloning methodsAll oligonucleotides were purchased from Sigma-Aldrich and are listed in Supplementary Table 4. Except for the ZF-SLiDE (described below), all PCR for cloning was performed with high-fidelity Herculase II Phusion DNA polymerase (Agilent, 600675); the cycling programs are listed in Supplementary Table 5. All restriction enzymes were purchased from New England Biolabs (NEB). # # # # # # # # # #
To view or add a comment, sign in
-
Hello, my name is Valentin von Werz, I joined the IBD group as a PhD candidate in April 2022. My research is focused on process development in the expansion of Natural Killer (NK) cells that will be used as cellular therapies in the fight against cancer. The goal is to change the expansion from static format to dynamic cultivation in a stirred tank bioreactor, in order to ensure the transferability between research laboratories into industrial processes. I try to identify and correlate the relationship between Critical Process Parameters (#CPPs) and the Critical Quality Attributes (#CQAs) for this relatively new therapeutic modality. With the knowledge about CPP-CQA correlations, I attempt to control the expansion process with the use of Process Analytical Technologies to generate highly efficient cellular products that help patients in need. #PAT #CQA #CPP #PhD
To view or add a comment, sign in
-
-
📣We are delighted to announce the completion of a global collaboration agreement with the Shanghai Model Organisms Center (SMOC). This five-year agreement extends the existing partnership and will provide unique immuno-oncology platforms and services from all Crown Bioscience facilities worldwide. This strategic alliance includes: ✅The purchase and supply of a broad range of genetically engineered mouse models, including thousands of knock-in and knock-out humanized models, ✅Genetically engineered cell line development services, ✅Custom development of GEMM models and MuPrime™ (our tumor homograft models) leveraging SMOC-engineered mice. Globally, Crown Bioscience research affiliates will benefit from uniform pricing, comprehensive IP protection, and licensing rights. This uniformity is accompanied by a shared commitment to research excellence, unrivaled quality standards, and scientific innovation. Read more about this agreement ➡️ https://hubs.la/Q02yp5vv0 #Bioscience #Biotech #ImmunoOncology #Innovation Shanghai Model Organisms Center, Inc.
Crown Bioscience Enters Global Agreement with Shanghai Model Organism Center
crownbio.com
To view or add a comment, sign in
-
🌐Immunotherapy research is ongoing, unlocking new possibilities every day! 🚀 🌟Can we collect a large compendium of clinical genomic data to quantitatively assess the predictive value of existing signatures? 🌟Would this help develop a better signature for immunotherapy response/resistance? More on the matter from Benjamin Haibe-Kains' talk today at the EuroBioc Bioconductor meeting in Belgium titled - PredictIO: Data and Packages For Meta-Analysis of Immunotherapy Clinical Trials in Cancer. #EuroBioc2023 #PredictIO #immunotherapy
EuroBioc2023 21/09 Session II
ugent.cloud.panopto.eu
To view or add a comment, sign in